Sign In
Get Clay Free →

Suggestions

    Sebastian Hasenfuss

    Seasoned Biopharma / Biotech leader - Former BCG - Former Scientist in oncology & inflammation

    Sebastian Hasenfuss is a seasoned Biopharma and Biotech leader with a diverse background in R&D, Strategy & Business Development, and Commercial sectors.

    Having managed teams of 1-4 professionals, Sebastian demonstrates a collaborative, adaptable, and agile leadership style, working closely with senior-level leaders in solving complex issues.

    He holds a PhD in Molecular Medicine from the University of Freiburg, Germany, with a GPA of 3.7/4.0 and BS/MS degrees in Molecular Medicine from the same university with a perfect GPA of 4.0/4.0.

    Sebastian Hasenfuss has a passion for drug development, particularly in oncology and inflammation, driven by the goal of positively impacting and transforming patients' lives.

    His professional experience includes roles such as Director of Corporate Development & Strategy at BioNTech US within BioNTech SE, Project Leader at Boston Consulting Group (BCG), and positions at L.E.K. Consulting where he served as a Senior Life Sciences Specialist and Life Sciences Specialist.

    Prior to these roles, Sebastian has also worked as an Intern in strategy and business development at Raqia, a Harvard Biotech startup, a Postdoctoral Research Fellow at Harvard Medical School, and as a PhD student at the Max Planck Institute of Immunbiology and Epigenetics.

    Highlights

    Nov 14 · biospace.com
    BioNTech to Acquire Biotheus to Boost Oncology Strategy - BioSpace
    BioNTech to Acquire Biotheus to Boost Oncology Strategy

    Related Questions

    What are Sebastian Hasenfuss's main responsibilities at BioNTech?
    How has Sebastian Hasenfuss contributed to BioNTech's strategic growth?
    What is Sebastian Hasenfuss's background before joining BioNTech?
    How does Sebastian Hasenfuss's role impact BioNTech's corporate strategy?
    What are some key projects Sebastian Hasenfuss has worked on at BioNTech?